GOLDENWELL BIOTECH, INC. (GWLL) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2024 | -$123.1K | -8.8% |
| 2023 | -$113.2K | +89.5% |
| 2022 | -$1.07M | -422.8% |
| 2021 | -$205.1K | -3143.8% |
| 2020 | -$6.3K | -173.6% |
| 2019 | -$2.3K | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2024 | -$123.1K | -8.8% |
| 2023 | -$113.2K | +89.5% |
| 2022 | -$1.07M | -422.8% |
| 2021 | -$205.1K | -3143.8% |
| 2020 | -$6.3K | -173.6% |
| 2019 | -$2.3K | — |